179 related articles for article (PubMed ID: 28011816)
1. Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.
McBride E; Marlow L; Forster AS; Moss S; Myles J; Kitchener H; Patnick J; Waller J
BMJ Open; 2016 Dec; 6(12):e014356. PubMed ID: 28011816
[TBL] [Abstract][Full Text] [Related]
2. Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme.
Bennett KF; Waller J; McBride E; Forster AS; Di Gessa G; Kitchener H; Marlow L
BJOG; 2021 Mar; 128(4):745-754. PubMed ID: 32783300
[TBL] [Abstract][Full Text] [Related]
3. Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study.
McBride E; Marlow LAV; Forster AS; Ridout D; Kitchener H; Patnick J; Waller J
Int J Cancer; 2020 Apr; 146(8):2113-2121. PubMed ID: 31251820
[TBL] [Abstract][Full Text] [Related]
4. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.
McCaffery K; Waller J; Forrest S; Cadman L; Szarewski A; Wardle J
BJOG; 2004 Dec; 111(12):1437-43. PubMed ID: 15663132
[TBL] [Abstract][Full Text] [Related]
5. Exploring reasons for variations in anxiety after testing positive for human papillomavirus with normal cytology: a comparative qualitative study.
McBride E; Marlow LAV; Bennett KF; Stearns S; Waller J
Psychooncology; 2021 Jan; 30(1):84-92. PubMed ID: 32909308
[TBL] [Abstract][Full Text] [Related]
6. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
7. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
[TBL] [Abstract][Full Text] [Related]
8. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
9. "If you can't treat HPV, why test for it?" Women's attitudes to the changing face of cervical cancer prevention: a focus group study.
McRae J; Martin C; O'Leary J; Sharp L;
BMC Womens Health; 2014 May; 14():64. PubMed ID: 24885650
[TBL] [Abstract][Full Text] [Related]
10. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
[TBL] [Abstract][Full Text] [Related]
11. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.
Kitchener HC; Almonte M; Gilham C; Dowie R; Stoykova B; Sargent A; Roberts C; Desai M; Peto J;
Health Technol Assess; 2009 Nov; 13(51):1-150, iii-iv. PubMed ID: 19891902
[TBL] [Abstract][Full Text] [Related]
12. 'I don't care whether it's HPV or ABC, I just want to know if I have cancer.' Factors influencing women's emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study.
O'Connor M; Costello L; Murphy J; Prendiville W; Martin CM; O'Leary JJ; Sharp L;
BJOG; 2014 Oct; 121(11):1421-9. PubMed ID: 24690225
[TBL] [Abstract][Full Text] [Related]
13. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study.
Maissi E; Marteau TM; Hankins M; Moss S; Legood R; Gray A
BMJ; 2004 May; 328(7451):1293. PubMed ID: 15166066
[TBL] [Abstract][Full Text] [Related]
14. Distinct Illness Representation Profiles Are Associated With Anxiety in Women Testing Positive for Human Papillomavirus.
McBride E; Marlow LAV; Chilcot J; Moss-Morris R; Waller J
Ann Behav Med; 2022 Jan; 56(1):78-88. PubMed ID: 33881145
[TBL] [Abstract][Full Text] [Related]
15. The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up.
Maissi E; Marteau TM; Hankins M; Moss S; Legood R; Gray A
Br J Cancer; 2005 Mar; 92(6):990-4. PubMed ID: 15785734
[TBL] [Abstract][Full Text] [Related]
16. Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.
Jayasinghe Y; Rangiah C; Gorelik A; Ogilvie G; Wark JD; Hartley S; Garland SM
J Clin Virol; 2016 Mar; 76 Suppl 1():S74-S80. PubMed ID: 26589584
[TBL] [Abstract][Full Text] [Related]
17. Patterns of anxiety and distress over 12 months following participation in HPV primary screening.
Marlow LAV; McBride E; Ridout D; Forster AS; Kitchener H; Waller J
Sex Transm Infect; 2022 Jun; 98(4):255-261. PubMed ID: 34344834
[TBL] [Abstract][Full Text] [Related]
18. Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
Gibson-Helm M; Slater T; MacDonald EJ; Stevenson K; Adcock A; Geller S; Parag V; Lambert C; Bennett M; Hibma M; Sykes P; Saville M; Hawkes D; Stanton JA; Clueard MA; Jelley G; Lawton B
PLoS One; 2023; 18(3):e0280643. PubMed ID: 36952546
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus infections and risks of cervical cancer: what do women know?
Pitts M; Clarke T
Health Educ Res; 2002 Dec; 17(6):706-14. PubMed ID: 12507346
[TBL] [Abstract][Full Text] [Related]
20. Socio-economic variations in anticipated adverse reactions to testing HPV positive: Implications for the introduction of primary HPV-based cervical screening.
O'Connor M; O'Leary E; Waller J; Gallagher P; Martin CM; O'Leary JJ; Sharp L;
Prev Med; 2018 Oct; 115():90-96. PubMed ID: 30144488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
